基本信息
浏览量:234
职业迁徙
个人简介
I have been an active member of MD Anderson’s world-renowned gynecologic diagnostic pathology team and contributed to multidisciplinary care of patients with gynecologic cancer since 1999. As an investigator, I have extensive experience in ovarian cancer research as demonstrated by >250 publications. My laboratory generated the first genetically defined model from transformed human ovarian epithelial cells, and we were among the first to define the key autocrine and paracrine mechanisms between epithelial cells and senescent stromal cells for ovarian cancer progression. More recently, my laboratory has made the surprising finding that polyploid giant cancer cells (PGCCs), generally believed to be non-dividing senescent cancer cells, can dedifferentiate into blastomere-like cancer stem cells, the earliest stage of embryonic development. The reprogramming is achieved via a novel cellular mechanism we term the giant cell cycle. PGCCs represent the most archaic cancer stem cells reported to date. I was principal investigator (PI) of a NIH-funded R01 grant and am co-investigator of several other NIH grants related to ovarian cancer. I am also co-PI of the tissue pathology core for MD Anderson’s SPORE in ovarian cancer and PI of multi-investigator grants from the Cancer Prevention Research Institute of Texas. I also direct the core resource for patient-derived xenografts (PDXs) for ovarian cancer and have established a cohort of more than 40 ovarian cancer PDX models and are in the process to develop organoids from each model and primary cancer. The overall goal of this proposal is to understand the molecular mechanisms regulating the growth and division of PGCCs and identify combinations of novel therapeutic agents to block PGCC growth and division in synergy with paclitaxel in ovarian PDX models. I have successfully administrated a productive research group for the past 18 years, and have collaborated with many investigators. In summary, I have a strong background in pathology and a productive research program in ovarian cancer. Together with our co-investigators, our team has all of the expertise needed to successfully carry out the proposed work.
研究兴趣
论文共 527 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Chae Young Han,Karen H Lu, Gwen Corrigan, Alexandra Perez, Sharlene D Kohring,Joseph Celestino,Deepak Bedi, Enrique Bedia,Therese Bevers,David Boruta,Matthew Carlson,Laura Holman,
Journal of clinical oncology : official journal of the American Society of Clinical Oncologypp.JCO2300141-JCO2300141, (2024)
Cancer Letters (2024): 216535
Archives of Biochemistry and Biophysics (2024): 109917-109917
Vera V. Levina, Brian Nolen,YunYun Su,Andrew K. Godwin,David Fishman,Jinsong Liu,Gil Mor,Larry G. Maxwell,Ronald B. Herberman,Miroslaw J. Szczepanski,Marta E. Szajnik, Elieser Gorelik,
crossref(2023)
Tsz-Lun Yeung, Cecilia S. Leung,Kwong-Kwok Wong,Goli Samimi, Melissa S. Thompson,Jinsong Liu, Tarrik M. Zaid, Sue Ghosh,Michael J. Birrer,Samuel C. Mok
crossref(2023)
crossref(2023)
Biochemical and biophysical research communications (2023): 16-22
Medical oncology (Northwood, London, England)no. 6 (2023): 1-2
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn